Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy. (2013)
Attributed to:
MICA: MRC Centre for Neuromuscular Diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0062114
PubMed Identifier: 23630626
Publication URI: http://europepmc.org/abstract/MED/23630626
Type: Journal Article/Review
Volume: 8
Parent Publication: PloS one
Issue: 4
ISSN: 1932-6203